Begin main content

Call for Patient Input: Dysport Therapeutic

January 3, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dysport Therapeutic Brand name Generic name Ma...

Calls for Patient Input: Cerdelga and Glatiramer acetate

December 15, 2016
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Cerdelga Brand name Generic name Manufacturer ...

New at CADTH — December 2016

December 13, 2016
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

New at CADTH — November 2016

November 30, 2016
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

CADTH’s Commitment to the Canadian Opioid Strategy

November 23, 2016
OTTAWA, November 23, 2016 — CADTH is pleased to announce our contribution to the comprehensive strategy to address the growing problem of misuse and abuse of opioids. The strategy was developed at the Opioid Conference and Summit, co-hosted by Federal Health Minister Jane Philpott and Ontario Provincial Health Minister Eric Hoskins in Ottawa on ...